A Randomized Trial of Progesterone in Women with Recurrent Miscarriages
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Progesterone is essential for the maintenance of pregnancy. However, whether progesterone supplementation in the first trimester of pregnancy would increase the rate of live births among women with a history of unexplained recurrent miscarriages is uncertain. METHODS: We conducted a multicenter, double-blind, placebo-controlled, randomized trial to investigate whether treatment with progesterone would increase the rates of live births and newborn survival among women with unexplained recurrent miscarriage. We randomly assigned women with recurrent miscarriages to receive twice-daily vaginal suppositories containing either 400 mg of micronized progesterone or matched placebo from a time soon after a positive urinary pregnancy test (and no later than 6 weeks of gestation) through 12 weeks of gestation. The primary outcome was live birth after 24 weeks of gestation. RESULTS: A total of 1568 women were assessed for eligibility, and 836 of these women who conceived naturally within 1 year and remained willing to participate in the trial were randomly assigned to receive either progesterone (404 women) or placebo (432 women). The follow-up rate for the primary outcome was 98.8% (826 of 836 women). In an intention-to-treat analysis, the rate of live births was 65.8% (262 of 398 women) in the progesterone group and 63.3% (271 of 428 women) in the placebo group (relative rate, 1.04; 95% confidence interval [CI], 0.94 to 1.15; rate difference, 2.5 percentage points; 95% CI, -4.0 to 9.0). There were no significant between-group differences in the rate of adverse events. CONCLUSIONS: Progesterone therapy in the first trimester of pregnancy did not result in a significantly higher rate of live births among women with a history of unexplained recurrent miscarriages. (Funded by the United Kingdom National Institute of Health Research; PROMISE Current Controlled Trials number, ISRCTN92644181.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Caution should be exercised when interpreting the results of these meta-analyses due to differences in the RCTs included in the analyses.199,200”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [199]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kumar, A., Begum, N., Prasad, S., Aggarwal, S., & Sharma, S. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.07.1251 · Cited by 93
RetractedPeto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Evaluation and treatment of recurrent pregnancy loss: a committee opinion
(2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.048 · Cited by 1,308
Rai, R., & Regan, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69204-0 · Cited by 1,227
Self-citationProgesterone and the Risk of Preterm Birth among Women with a Short Cervix
Fonseca, E. B., Celik, E., Parra, M., Singh, M., & Nicolaides, K. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067815 · Cited by 1,086
da Fonseca, E. B., Bittar, R. E., Carvalho, M. H. B., & Zugaib, M. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.41 · Cited by 789
Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study
Stephenson, M. D. (2002) · Human Reproduction · doi:10.1093/humrep/17.2.446 · Cited by 522
A comparison of placental development and endocrine functions between the human and mouse model
Malassine, A., Frendo, J. L., & Evain-Brion, D. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg043 · Cited by 476
Targeted drug delivery in gynaecology: the first uterine pass effect
Bulletti, C., de Ziegler, D., Flamigni, C., Giacomucci, E., Polli, V., Bolelli, G., & Franceschetti, F. (1997) · Human Reproduction · doi:10.1093/humrep/12.5.1073 · Cited by 245
Progestogen for preventing miscarriage
Oates-Whitehead, R., Haas, D., & Carrier, J. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003511 · Cited by 224
Research works printed but not linked: 2
- Haas DM, 2013, Cochrane Database Syst Rev, 10, CD003511
- Levine L, 1964, West J Surg Obs Gynecol, 72, 30
Cited by
Items 301–309 of 309
Song, Z., Jiang, Y., Zhu, Z., Che, Y., Li, S., & Zhao, A. M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1875194
Progesterone in the prevention of recurrent miscarriage – up-to-date review
Remjasz, K., & Ciebiera, M. (2024) · Wiedza Medyczna · doi:10.36553/wm.168
Dugalić, S., Gojnić-Dugalić, M., Milinčić, M., & Ivanović, K. (2026) · Children · doi:10.3390/children13070953
“Therefore, available ART-related evidence cannot reliably isolate the independent developmental contribution of progesterone and should not be generalized to obstetric indications such as threatened miscarriage, recurrent pregnancy loss, or short cervix [25,26].”
Immuno-modulatory medications in reproductive medicine
Eapen, A. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-21987-0.00007-9
Self-citationA Predictive Model for Pregnancy Loss Among Reproductive Aged Women
Ahubele, B. O., Oguma, L., & Obahiagbon, K. O. (2026) · FUDMA Journal of Sciences · doi:10.33003/fjs-2026-1015-5975
Boyarsky, K. Y., Zorina, I., Korneeva, I., L’vova, A. G., Smirnova, A. А., & Temirbulatov, R. R. (2026) · Russian Journal of Human Reproduction · doi:10.17116/repro20263204139
Doukaga, K.-B., & Wang, S. (2026) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20263449
Early Pregnancy for the On‐Call Gynaecologist
Laws, I., Smith, G., & Ross, J. (2026) · The Obstetrician & Gynaecologist · doi:10.1111/tog.70058
Self-citationKolawole, O. O., Odukoya, F. S., Ogide, P. O., & Sylva-Oriji, F. (2026) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20264039
Metadata
- Authors
- Coomarasamy, A., Williams, H., Truchanowicz, E., Seed, P. T., Small, R., Quenby, S., Gupta, P., Dawood, F., Koot, Y. E. M., Bender Atik, R., Bloemenkamp, K. W. M., Brady, R., Briley, A. L., Cavallaro, R., Cheong, Y. C., Chu, J. J., Eapen, A., Ewies, A., Hoek, A., Kaaijk, E. M., Koks, C. A. M., Li, T.-C., MacLean, M., Mol, B. W., Moore, J., Ross, J. A., Sharpe, L., Stewart, J., Vaithilingam, N., Farquharson, R. G., Kilby, M. D., Khalaf, Y., Goddijn, M., Regan, L., & Rai, R.
- Affiliations
- St Thomas' Hospital (GB)
- University of Birmingham (GB)
- Heart of England NHS Foundation Trust (GB)
- University of Warwick (GB)
- Liverpool Womens NHS Foundation Trust (GB)
- University Medical Center Utrecht (NL)
- Leiden University Medical Center (NL)
- Imperial College London (GB)
- Princess Anne Hospital (GB)
- Sandwell & West Birmingham Hospitals NHS Trust (GB)
- University of Groningen (NL)
- OLVG (NL)
- Máxima Medisch Centrum (NL)
- Royal Hallamshire Hospital (GB)
- University Hospital Crosshouse (GB)
- The University of Adelaide (AU)
- Nottingham University Hospitals NHS Trust (GB)
- King's College Hospital NHS Foundation Trust (GB)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Portsmouth Hospitals NHS Trust (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-11-26
- Volume
- 373
- Issue
- 22
- Pages
- 2141-2148
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2236902456
- Cited by
- 312
- References
- 22
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 24 · 2023: 24 · 2022: 22 · 2021: 33 · 2020: 35 · 2019: 28 · 2018: 38 · 2017: 36 · 2016: 30 · 2015: 1
- FWCI
- 17.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- University of Birmingham Research Portal (University of Birmingham) (acceptedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Funders
- National Institute for Health and Care Research (08/38/01)
- Medical Research Council
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- progesterone supplementation, recurrent pregnancy loss, unexplained recurrent spontaneous abortion, first trimester, live birth rate, micronized progesterone, miscarriage, neonatal survival
- MeSH terms
- Abortion, Habitual, Administration, Intravaginal, Adult, Double-Blind Method, Female, Gestational Age, Humans, Pregnancy, Pregnancy Trimester, First, Progesterone, Body Mass Index, Treatment Failure, Live Birth
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.